Why this is boom-time for physical corporate events in some nations following COVID vaccinations - future of conferencing and virtual events, keynote speakers. Get ready for hyper-agile pop-up events at very short notice. Companies have to meet to survive

The Truth about COVID-19. Impact on health care, vaccines, pharma. Health care Keynote Speaker

Life Beyond Coronavirus. Virtual Event Futurist Keynote Speaker.High audience engagement on COVID-19

Q+A on Coronavirus: global impact - with Futurist physician advisor to corporations and government. Coronavirus / COVID-19 keynote speaker

Why many don't trust government info about health scares, and why most people distrust marketing messages - truth about social media. Marketing keynote speaker

Future of Cars: auto industry trends. Robot drivers, e-vehicles, flying cars - keynote speaker

Future of Marketing - key messages, seconds before start of my marketing keynote - VIDEO

Future of Personalised Mailings. Totally customised high speed print, programmatic marketing keynote- VIDEO

Next-generation print marketing - programmatic printing, integrated marketing - keynote speaker VIDEO

Totally personal books: future of book printing, customisation, short print runs. Publishing keynote VIDEO

Future of Programmatic Marketing. Integrate print and e-marketing. Futurist keynote speaker VIDEO

Feed Your Gut Microbes! Huge impact of nutrition on health and Microbiome. Futurist health keynote VIDEO

STI571 hope of new cure for bone cancer

Futurist Keynote Speaker: Posts, Slides, Videos - Health, Coronavirus Speaker Future Pharma Keynotes

What is the truth about STI571?  Does STI571 cure cancer?  STI571 side effects.  Summary of latest research and news on STI571 by Dr Patrick Dixon MA MBBS.  Please not that STI571 is often mispelled as ST1571, especially by those looking on the net.

STI571 is a new cancer drug which appears to have sent 95% of patients with CML (chronic myeloid leukaemia or chronic myelogenous leukemia) into remission in early trials.  In one UK trial 30 out of 31 people had white blood cell counts which returned to normal after a month on STI571 while the final patient's blood count also became normal soon after.

All 31 patients were selected from the 50% of all patients with CML who are sensitive to the STI571. Eleven showed significant improvement and three of those eleven cleared their bone marrow of leukaemic cells completely. 

Side effects seem very few from the daily STI571 tablet, certainly a lot less than bone marrow transplant or interferon.

Now Novartis who makes STI571 is under pressure together with the regulatory authorities to bring the drug to market as quickly as possible.  The US licence application for STI571 is imminent.  The US Food and Drug Administration have agreed to an "accelerated STI571 approval" which means the drug will undergo only two rounds of tests, not three.

Chronic myeloid leukaemia is diagnosed in around 1,000 people each year in the UK. It is caused by the Philadelphia chromosome - an abnormality that arises when part of one chromosome becomes attached to another.  STI571 works by blocking enzymes only used in these cancer cells.

Related news items:
Newer news items:
Older news items:

Thanks for promoting with Facebook LIKE or Tweet. Really interested to read your views. Post below.

Emanuel Turchetto
June 08, 2011 - 23:50

It seems that the drug STI571 needs do be accompained by antibiotica or a human natura sort of protein is going to attack the pills hormon before this can penetrated the cancerous cells. Italian scientists have apparently found out this trick.

October 22, 2010 - 02:22
Fly the ribbon

Could you please let me know how to get a pink breast cancer ribbon on my facebook page?

Join the Debate! What are your own views?



Search for your future

Our cookie policy

We use cookies for statistical purposes. To comply with the e-Privacy Directive we need to ask your consent to place these cookies on your computer.

Your use of this site indicates acceptance of these terms. I accept